Elion Therapeutics
Dedicated to developing new therapies to combat life-threatening invasive fungal infections, addressing critical unmet needs in antifungal efficacy and safety.
Employees
Enterprise value
$324—486m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $81.0m | Series B | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads